Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Cellular Biomedicine Group Enters Into Strategic Licensing and Collaboration Agreement with a Global Leader in CAR-T Cell Therapy for Patients in China

Friday, September 28, 2018

Cellular Biomedicine Group Inc today announced it has entered into a strategic licensing and collaboration agreement with Novartis to manufacture and supply the CART cell therapy Kymriah tisagenlecleucel in China Novartis will be the exclusive holder...

Dova Pharmaceuticals and Salix Enter Into Exclusive Co-Promotion Agreement For DOPTELET® (Avatrombopag)

Friday, September 28, 2018

Dova Pharmaceuticals Inc a specialty pharmaceutical company focused on acquiring developing and commercializing drug candidates for diseases where there is a high unmet need and Salix Pharmaceuticals Salix one of the largest specialty pharmaceutical...

Selexis SA and Hoba Therapeutics Team Up to Advance Hoba’s Investigational Neuropathic Pain Treatment into the Clinic

Thursday, September 27, 2018

Selexis SA and Hoba Therapeutics announced today that they have entered into an agreement to advance the development of Hobas clinical candidate HB rhMeteorin for the treatment of peripheral neuropathic pain Under the agreement Selexis is leveraging...

Alexion to Acquire Syntimmune

Thursday, September 27, 2018

Alexion Pharmaceuticals Incand Syntimmune today announced that they have entered into a definitive agreement for Alexion to acquire Syntimmune a clinicalstage biotechnology company developing antibody therapeutics targeting the neonatal Fc receptor F...

PeptiDream Announces Drug Discovery and Development Agreement with Santen Pharmaceutical

Wednesday, September 26, 2018

PeptiDream Inc a public Kanagawabased biopharmaceutical company announced today that it has entered into a broadbased multitarget discovery and development agreement with Osakabased Santen Pharmaceuticals Co Ltd Santen Under the agreement PeptiDream...

Tris Pharma Expands ADHD Portfolio with Acquisition of NextWave Pharmaceuticals

Wednesday, September 26, 2018

Tris Pharma Inc Tris a pharmaceutical company focused on developing innovative technologybased therapeutic products that address unmet patient needs today announced the acquisition of NextWave Pharmaceuticals NextWave a wholly owned subsidiary of Pfi...

Cerveau Technologies Inc. Signs Research Agreement with Ionis Pharmaceuticals, Inc. for Novel Tau Imaging Agent

Tuesday, September 25, 2018

Cerveau Technologies Inc today announced a research collaboration agreement with Ionis Pharmaceuticals Inc for use of FMK an investigational imaging agent to be used in Positron Emission Tomography PET scans for assessing the status and progression o...

Knight Therapeutics and Jaguar Health Announce Strategic Partnership

Tuesday, September 25, 2018

Knight Therapeutics Inc a Canadianbased specialty pharmaceutical company focused on acquiring inlicensing selling and marketing innovative prescription and overthecounter pharmaceutical products and Jaguar Health Inc a commercial stage pharmaceutical...

MEBIAS Discovery Receives Grant from NIDA to Advance Its Signaling-Pathway Selective Mu-Opioid Receptor Drug Candidate

Monday, September 24, 2018

MEBIAS Discovery an emerging leader in the field of drug discovery targeting Gprotein coupled receptors has secured grant funding from the National Institute of Drug Abuse NIDA to progress a muopioid receptor candidate Preclinical data presented last...

Seattle Genetics Announces ADCETRIS® (Brentuximab Vedotin) Approval in Japan for Frontline Hodgkin Lymphoma

Monday, September 24, 2018

Seattle Genetics Inc today announced that its collaborator Takeda Pharmaceutical Company Limited Takeda has received approval from the Japanese Ministry of Health Labour and Welfare for ADCETRIS brentuximab vedotin in combination with doxorubicin vin...